Skip to Main Content

Paper Details

Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests.
Circulation
3
2024
Acute Coronary Syndrome, Lipoprotein(a), acs, acute coronary syndrome, alirocumab, cardiovascular, ia, ldl-c, lipoprotein(a), mace, participants, patients, pcsk9, pcsk9i
Author NameAffiliation
Deepak L BhattIcahn School of Medicine at Mount Sinai Health System
Robert A HarringtonStanford Center for Clinical Research, Stanford University
Sotirios TsimikasUniversity of California San Diego
  • 1 - 3

Datasets

Release 1.2